Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-25-046831
Filing Date
2025-05-22
Accepted
2025-05-22 16:01:32
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0242519-s3_abvcbio.htm S-3 340588
2 OPINION OF HUNTER TAUBMAN FISCHER & LI LLC ea024251901ex5-1_abvcbio.htm EX-5.1 30920
3 CONSENT OF SIMON & EDWARD, LLP ea024251901ex23-1_abvcbio.htm EX-23.1 3191
4 CALCULATION OF FILING FEE TABLE ea024251901ex-fee_abvcbio.htm EX-FILING FEES 35008
5 GRAPHIC ex5-1_001.jpg GRAPHIC 4439
6 GRAPHIC image_004.jpg GRAPHIC 15847
7 GRAPHIC image_003.jpg GRAPHIC 6405
  Complete submission text file 0001213900-25-046831.txt   448170
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-287512 | Film No.: 25976961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)